Physician profile
Michael Sullivan
NPI 1588827174
$618.20
in general payments reported to CMS, 2019-2025
15 companies · $77.69 in 2025
The $77.69 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.35 · 2020: $19.99 · 2021: $34.50 · 2022: $57.83 · 2023: $257 · 2024: $121 · 2025: $77.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $455.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $155.87 | 2022-2024 | Coolseal Generator |
| Ethicon US, LLC | $56.54 | 2019-2020 | |
| Abbott Laboratories | $55.56 | 2023-2024 | Freestyle Libre 3 |
| Galvanize Therapeutics, INC | $55.48 | 2025 | Aliya System |
| Abbvie INC. | $48.30 | 2023-2024 | Synthroid |
| Amneal Pharmaceuticals LLC | $43.15 | 2021-2023 | Unithroid |
| Corcept Therapeutics | $42.48 | 2023 | Korlym |
| Novo Nordisk INC | $30.51 | 2023-2024 | Sogroya |
| Sanara Medtech INC. | $26.12 | 2023 | Celleraterx |
| Tempus Ai, INC | $22.21 | 2025 | Xt Cdx |
| Davol INC. | $20.06 | 2021 | |
| Embecta Corp. | $18.21 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Alexion Pharmaceuticals, INC. | $15.00 | 2022 | |
| Ibsa Pharma INC. | $14.91 | 2022 | |
| Eisai INC. | $13.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.